Crown Electrokinetics CEO, Mr. Doug Croxall Releases Shareholder Letter on Intellectual Property Valuation and Market Outlook

April 12, 2022

Chemicals

BioLargo PFAS Removal Technology Meets New US Drinking Water Standards

April 15, 2024
BioLargo Achieved 108% Year-Over-Year Revenue Growth in 2023

April 2, 2024
BioLargo Year-End 2023 Earnings Results Webcast and Conference Call on Tuesday, April 2, 2024 – 5:00 PM Eastern Time

April 1, 2024
BioLargo to Present at The LD Micro Invitational XIV

March 25, 2024